Cyril Pottier

4.0k citations

25 papers · 655 indexed · h-index 13

Co-authors: Rosa Rademakers Dominique Campion Anne Rovelet‐Lecrux Thomas A. Ravenscroft Mónica Sánchez-Contreras Thierry Frébourg Didier Hannequin David Wallon
Topics: Amyotrophic Lateral Sclerosis Research (8 papers)Genomics and Rare Diseases (6 papers)Alzheimer's disease research and treatments (5 papers)
Cited by: Neurology Physiology
Journals: PLoS ONE Brain Journal of Neurochemistry
Partner nations: United States France Belgium

In The Last Decade

Cyril Pottier

24 papers receiving 652 citations

Peers

Countries citing papers authored by Cyril Pottier

Since Specialization

Citations

This map shows the geographic impact of Cyril Pottier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cyril Pottier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cyril Pottier more than expected).

Fields of papers citing papers by Cyril Pottier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cyril Pottier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cyril Pottier. The network helps show where Cyril Pottier may publish in the future.

Co-authorship network of co-authors of Cyril Pottier

This figure shows the co-authorship network connecting the top 25 collaborators of Cyril Pottier. A scholar is included among the top collaborators of Cyril Pottier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cyril Pottier. Cyril Pottier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2 2025 ·Neurotherapeutics ·Jacob Marsh,Guangming Huang,Kevin M. Bowling,Alan E. Renton,(unknown),T. Blake Ball,Cyril Pottier,Carlos Cruchaga,Gregory S. Day,Randall J. Bateman,Jorge J. Llibre‐Guerra,Eric McDade,Celeste M. Karch	1
2	Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosis 2025 ·Human Molecular Genetics ·Maulikkumar Patel,Cyril Pottier,Kang-Hsien Fan,(unknown),M. J. Johnson,Muhammad Ali,Menghan Liu,Priyanka Gorijala,John Budde,(unknown),Ann D. Cohen,James T. Becker,Beth E. Snitz,Howard Aizenstein,Lorna M. Lopez,John C. Morris,M. Ilyas Kamboh,Carlos Cruchaga	1
3	High-sensitivity plasma proteomics reveals disease-specific signatures and predictive biomarkers of Alzheimer’s disease phenotypes in a large mixed-dementia cohort 2025 ·Molecular Neurodegeneration ·(unknown),Jigyasha Timsina,Muhammad Junaid Ali,Yike Chen,Menghan Liu,(unknown),Cyril Pottier,Geoffrey K. Feld,(unknown),Tammie L.S. Benzinger,Cyrus A. Raji,Beau M. Ances,Brian A. Gordon,Julie K. Wisch,Suzanne E. Schindler,John C. Morris,David M. Holtzman,Laura Ibáñez,Carlos Cruchaga	0
4	Abundant transcriptomic alterations in the human cerebellum of patients with a C9orf72 repeat expansion 2024 ·Acta Neuropathologica ·(unknown),Mariely DeJesus‐Hernandez,Shulan Tian,Sofia Pereira das Neves,Richard Crook,NiCole A. Finch,Matthew Baker,Cyril Pottier,(unknown),(unknown),Ronald C. Petersen,David S. Knopman,Keith A. Josephs,Björn Oskarsson,Sandro Dá Mesquita,Leonard Petrucelli,Tania F. Gendron,Dennis W. Dickson,Rosa Rademakers,Marka van Blitterswijk	3
5	Impact of variant-level batch effects on identification of genetic risk factors in large sequencing studies 2021 ·PLoS ONE ·Daniel P. Wickland,Yingxue Ren,Jason P. Sinnwell,Joseph S. Reddy,Cyril Pottier,Vivekananda Sarangi,Minerva M. Carrasquillo,Owen A. Ross,Steven G. Younkin,Nilüfer Ertekin‐Taner,Rosa Rademakers,Matthew E. Hudson,Liudmila S. Mainzer,Joanna M. Biernacka,Yan W. Asmann	5
6	Multilocus sequence typing of strains from the Cryptococcus gattii species complex from different continents 2021 ·Mycoses ·Virginie Bellet,Frédéric Roger,Donika Krasteva,(unknown),(unknown),Cyril Pottier,Sébastien Bertout	6
7	Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations 2021 ·Brain ·Cyril Pottier,Ligia Mateiu,Matthew Baker,Mariely DeJesus‐Hernandez,Cristina T. Vicente,NiCole A. Finch,Shulan Tian,Marka van Blitterswijk,Melissa E. Murray,Yingxue Ren,Leonard Petrucelli,Björn Oskarsson,Joanna M. Biernacka,Neill R. Graff‐Radford,Bradley F. Boeve,Ronald C. Petersen,Keith A. Josephs,Yan W. Asmann,Dennis W. Dickson,Rosa Rademakers	7
8	Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients 2020 ·Neurobiology of Aging ·Merel O. Mol,Jeroen van Rooij,Tsz Hang Wong,Shamiram Melhem,Annemieke J.M.H. Verkerk,Anneke J.A. Kievit,Rick van Minkelen,Rosa Rademakers,Cyril Pottier,Laura Donker Kaat,Harro Seelaar,John C. van Swieten,Elise G.P. Dopper	25
9	Clinicopathologic correlations in a family with aTBK1mutation presenting as primary progressive aphasia and primary lateral sclerosis 2019 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Veronica Hirsch‐Reinshagen,(unknown),Ging‐Yuek Robin Hsiung,Cyril Pottier,Matt Baker,Ralph B. Perkerson,Rosa Rademakers,(unknown),Dean Foti,Ian R. Mackenzie	23
10	Identification of missing variants by combining multiple analytic pipelines 2018 ·BMC Bioinformatics ·Yingxue Ren,Joseph S. Reddy,Cyril Pottier,Vivekananda Sarangi,Shulan Tian,Jason P. Sinnwell,Shannon K. McDonnell,Joanna M. Biernacka,Minerva M. Carrasquillo,Owen A. Ross,Nilüfer Ertekin‐Taner,Rosa Rademakers,Matthew E. Hudson,Liudmila S. Mainzer,Yan W. Asmann	6
11	Identification of compound heterozygous variants in OPTN in an ALS-FTD patient from the CReATe consortium: a case report 2018 ·Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration ·Cyril Pottier,Evadnie Rampersaud,Matt Baker,Gang Wu,Joanne Wuu,Jacob L. McCauley,Stephan Züchner,Rebecca Schüle,(unknown),Sumaira Hussain,Anne Cooley,Marielle Wallace,Jinghui Zhang,J. Paul Taylor,Michael Benatar,Rosa Rademakers	16
12	Three VCP Mutations in Patients with Frontotemporal Dementia 2018 ·Journal of Alzheimer s Disease ·Tsz Hang Wong,Cyril Pottier,David Hondius,Lieke Meeter,Jeroen van Rooij,(unknown),(unknown),Rick van Minkelen,Cornelia M. van Duijn,Annemieke J.M. Rozemüller,Harro Seelaar,Rosa Rademakers,John C. van Swieten	20
13	Clinical and neuropathological features of ALS/FTD with TIA1 mutations 2017 ·Acta Neuropathologica Communications ·Veronica Hirsch‐Reinshagen,Cyril Pottier,Alexandra M. Nicholson,Matt Baker,Ging‐Yuek Robin Hsiung,Charles Krieger,Pheth Sengdy,Khrista Boylan,Dennis W. Dickson,Marsel Mesulam,Sandra Weıntraub,Eileen H. Bigio,Lorne Zinman,Julia Keith,Ekaterina Rogaeva,Sasha Živković,David Lacomis,J. Paul Taylor,Rosa Rademakers,Ian R. Mackenzie	38
14	Genetics of FTLD: overview and what else we can expect from genetic studies 2016 ·Journal of Neurochemistry ·Cyril Pottier,Thomas A. Ravenscroft,Mónica Sánchez-Contreras,Rosa Rademakers	100
15	Alzheimer disease: modeling an Aβ-centered biological network 2016 ·Molecular Psychiatry ·Dominique Campion,Cyril Pottier,Gaël Nicolas,Kilan Le Guennec,Anne Rovelet‐Lecrux	36
16	De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease 2015 ·Molecular Psychiatry ·Anne Rovelet‐Lecrux,Camille Charbonnier,David Wallon,Gaël Nicolas,Matthew Seaman,Cyril Pottier,Sophia Y. Breusegem,Premendu P. Mathur,Pranitha Jenardhanan,Kilan Le Guennec,Aamir S. Mukadam,Olivier Quenez,Sophie Coutant,Simon Rousseau,(unknown),Anne Boland,J.-F. Deleuze,Thierry Frébourg,Didier Hannequin,Dominique Campion,(unknown)	74
17	PDGFB Partial Deletion: a New, Rare Mechanism Causing Brain Calcification with Leukoencephalopathy 2014 ·Journal of Molecular Neuroscience ·Gaël Nicolas,Anne Rovelet‐Lecrux,Cyril Pottier,Olivier Martinaud,David Wallon,(unknown),(unknown),Françoise Chapon,(unknown),Elisabeth Tournier‐Lasserve,Thierry Frébourg,Dominique Campion,Didier Hannequin	43
18	A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia 2014 ·European Journal of Human Genetics ·Gaël Nicolas,Agnès Jacquin,Christel Thauvin‐Robinet,Anne Rovelet‐Lecrux,Olivier Rouaud,Cyril Pottier,Marie‐Hélène Aubriot‐Lorton,Stéphane Rousseau,David Wallon,C. Duvillard,Yannick Béjot,Thierry Frébourg,Maurice Giroud,Dominique Campion,Didier Hannequin	37
19	Biomechanical findings in rats undergoing fascial reconstruction with graft materials suggested as an alternative to polypropylene 2009 ·Neurourology and Urodynamics ·(unknown),(unknown),Federico Spelzini,Cyril Pottier,Dirk De Ridder,Jan Deprest	20
20	Synthetic and biodegradable prostheses in pelvic floor surgery 2005 ·International Congress Series ·Jan Deprest,Filip Claerhout,Fang Zheng,Maja Konstantinovic,Federico Spelzini,(unknown),Cyril Pottier,Eric Verbeken,Dirk De Ridder	3

About Cyril Pottier

Cyril Pottier is a scholar working on Neurology, Neurology and Genetics, having authored 25 papers that have together received 655 indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (8 papers), Genomics and Rare Diseases (6 papers) and Alzheimer's disease research and treatments (5 papers). The work is most often cited by research in Neurology (195 citations), Neurology (195 citations) and Physiology (218 citations). Cyril Pottier has collaborated with scholars based in United States, France and Belgium. Frequent co-authors include Rosa Rademakers, Dominique Campion, Anne Rovelet‐Lecrux, Thomas A. Ravenscroft, Mónica Sánchez-Contreras, Thierry Frébourg, Didier Hannequin, David Wallon, Gaël Nicolas and Stéphane Rousseau. Their work appears in journals such as PLoS ONE, Brain and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact